These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 37520560)
1. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta. O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR Front Immunol; 2023; 14():1221532. PubMed ID: 37520560 [TBL] [Abstract][Full Text] [Related]
2. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Kobayashi S; Watanabe T; Suzuki R; Furu M; Ito H; Ito J; Matsuda S; Yoshitomi H Eur J Immunol; 2016 Feb; 46(2):360-71. PubMed ID: 26541894 [TBL] [Abstract][Full Text] [Related]
3. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. Di Modugno F; Di Carlo A; Spada S; Palermo B; D'Ambrosio L; D'Andrea D; Morello G; Belmonte B; Sperduti I; Balzano V; Gallo E; Melchionna R; Panetta M; Campo G; De Nicola F; Goeman F; Antoniani B; Carpano S; Frigè G; Warren S; Gallina F; Lambrechts D; Xiong J; Vincent BG; Wheeler N; Bortone DS; Cappuzzo F; Facciolo F; Tripodo C; Visca P; Nisticò P EBioMedicine; 2024 Mar; 101():105003. PubMed ID: 38340557 [TBL] [Abstract][Full Text] [Related]
4. PD-1 Li JP; Wu CY; Chen MY; Liu SX; Yan SM; Kang YF; Sun C; Grandis JR; Zeng MS; Zhong Q J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253636 [TBL] [Abstract][Full Text] [Related]
5. Intratumoral CXCL13 Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528 [TBL] [Abstract][Full Text] [Related]
6. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13 Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519 [TBL] [Abstract][Full Text] [Related]
7. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral CXCL13 Wang J; Liang Y; Xue A; Xiao J; Zhao X; Cao S; Li P; Dong J; Li Y; Xu Z; Yang L J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39244216 [TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486 [TBL] [Abstract][Full Text] [Related]
10. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285 [TBL] [Abstract][Full Text] [Related]
11. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC. Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552 [TBL] [Abstract][Full Text] [Related]
12. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Liu Y; Ye SY; He S; Chi DM; Wang XZ; Wen YF; Ma D; Nie RC; Xiang P; Zhou Y; Ruan ZH; Peng RJ; Luo CL; Wei PP; Lin GW; Zheng J; Cui Q; Cai MY; Yun JP; Dong J; Mai HQ; Xia X; Bei JX Nat Commun; 2024 Sep; 15(1):7713. PubMed ID: 39231979 [TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome. Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812 [TBL] [Abstract][Full Text] [Related]
14. An imbalance between blood CD4 Cao G; Wang P; Cui Z; Yue X; Chi S; Ma A; Zhang Y Mol Immunol; 2020 Sep; 125():1-8. PubMed ID: 32610164 [TBL] [Abstract][Full Text] [Related]
15. CXCL13-mediated recruitment of intrahepatic CXCR5 Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223 [TBL] [Abstract][Full Text] [Related]